These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5415744)

  • 1. Agnogenic myeloid metaplasia; its current managment.
    Silverstein MN
    Minn Med; 1970 Mar; 53(3):257-9. PubMed ID: 5415744
    [No Abstract]   [Full Text] [Related]  

  • 2. [Splenectomy, androgens and corticosteroids in the therapy of myelofibrosis. Description of 2 clinical cases].
    Perugini S; Lusvarghi E; Sternieri E; Ferrari G
    Minerva Med; 1966 Sep; 57(70):2821-34. PubMed ID: 4288203
    [No Abstract]   [Full Text] [Related]  

  • 3. Splenectomy for agnogenic myeloid metaplasia.
    Coon WW; Liepman MK
    Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenectomy for agnogenic myeloid metaplasia.
    Gomes MR; Silverstein MN; Remine WH
    Surg Gynecol Obstet; 1967 Jul; 125(1):106-8. PubMed ID: 6026679
    [No Abstract]   [Full Text] [Related]  

  • 5. Esophageal varices in agnogenic myeloid metaplasia: disappearance after splenectomy. A case report.
    Sullivan A; Rheinlander H; Weintraub LR
    Gastroenterology; 1974 Mar; 66(3):429-32. PubMed ID: 4813509
    [No Abstract]   [Full Text] [Related]  

  • 6. Agnogenic myeloid metaplasia: role of splenectomy.
    Marks C; Ahmadi M
    Postgrad Med J; 1969 Apr; 45(522):261-5. PubMed ID: 5821186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroleukemia following erythropoietin therapy, extramedullary hematopoiesis, and splenectomy in a patient with myelofibrosis and myeloid metaplasia.
    Coleman TA; Hamill RL; Ford SM
    Am J Hematol; 2001 Jul; 67(3):214-5. PubMed ID: 11391725
    [No Abstract]   [Full Text] [Related]  

  • 8. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current therapeutic possibilities in idiopathic myelofibrosis. Observations on 47 cases].
    Perugini S; Ascari E; Fontana G
    Clin Ter; 1968 Apr; 45(1):21-60. PubMed ID: 4897957
    [No Abstract]   [Full Text] [Related]  

  • 10. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenectomy for massive splenomegaly.
    Coon WW
    Surg Gynecol Obstet; 1989 Sep; 169(3):235-7. PubMed ID: 2772794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myeloid metaplasia in the course of splenic miliary tuberculosis and results obtained by splenectomy].
    Aksoy M; Sagun N; Erdem S; Başerer G
    Turk Tip Cemiy Mecm; 1967 Feb; 33(2):92-7. PubMed ID: 6066641
    [No Abstract]   [Full Text] [Related]  

  • 13. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
    Brenner B; Nagler A; Tatarsky I; Hashmonai M
    Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive hepatomegaly following splenectomy for myeloid metaplasia.
    Grieco A; Manna R; Mancini R; Gambassi G
    Am J Med; 1988 Apr; 84(4):797. PubMed ID: 3400674
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications for splenectomy in the anemic forms of myelofibrosis with myeloid metaplasia of the spleen].
    Dechavanne M; Viala JJ; Barbier Y; Revol L
    Sem Hop; 1972 Apr; 48(17):1187-92. PubMed ID: 4342370
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of splenectomy on teardrop-shaped erythrocytes in agnogenic myeloid metaplasia.
    DiBella NJ; Silverstein MN; Hoagland HC
    Arch Intern Med; 1977 Mar; 137(3):380-1. PubMed ID: 843155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon therapy for agnogenic myeloid metaplasia complicated by immune hemolytic anemia.
    Radin AI; Buckley P; Duffy TP
    Hematol Pathol; 1991; 5(2):83-8. PubMed ID: 1894585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune haemolytic anaemia as the presenting manifestation of agnogenic myeloid metaplasia.
    Mohite U; Pathare A; al Kindi S; Hiwase D; Vadakkepat N; Knox-Macaulay H
    Haematologia (Budap); 2002; 32(4):495-9. PubMed ID: 12803124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Agnogenic myelofibrosis].
    Avilés A; Monroy L; Ambriz R; Butrón L; Pizzuto J
    Gac Med Mex; 1981 Mar; 117(3):110-7. PubMed ID: 7327351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.